Promakhos Therapeutics

Summer 2021Active

A therapeutics platform for curing inflammatory disorders

Save

Promakhos Therapeutics

Summer 2021Active

A therapeutics platform for curing inflammatory disorders

Save

Company details

We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.

Location

Boston, MA, USA

Founded

Unknown

Upgrade to Pro, then request the Promakhos Therapeutics teardown.

This company does not have a completed analysis yet. Choose a Pro plan first, then use one of your 5 monthly research requests to have our agent investigate Promakhos Therapeutics. The full teardown, rebuild plan, and technical specs unlock when it lands.

Use Pro to request the first Promakhos Therapeutics teardown and keep the finished report in your account.
Read every completed teardown and rebuild plan already in the database.
Unlock implementation-ready technical specs and 5 fresh research requests each month.

Choose your Pro plan

$20/ month

Find one worth rebuilding, get the teardown, open the implementation-ready specs, and use fresh report requests when you want deeper research.

See Pro plans

Full teardown library

Specs for every company

5 fresh requests / month

CLI for agent imports